Boston Beer's stock falls 6% after profit miss as company lowers guidance
Boston Beer Co.'s stock (SAM) tumbled 6% after hours Thursday, after the brewer of Sam Adams beer . The company posted net income of $45.3 million, or $3.70 a share, for the quarter, up from $27.3 million, or $2.21 a share, in the year-earlier period. The number included a non-cash brand impairment charge of 96 cents a share. Revenue fell 0.9% to $601.6 million. The FactSet consensus was for EPS of $4.08 and revenue of $594.0 million. Depletions, a metric that measures the number of cases sold by distributors to retailers, fell 6%, due to decreases in the company's Truly, Angry Orchard, Samuel Adams and Dogfish Head brands, which were partially offset by increases in its Twisted Tea and Hard Mountain Dew brands. The company narrowed and lowered its EPS guidance range and now expects EPS of $6.04 to $8.04 compared with prior guidance of $6.00 to $10.00. It expects depletions to be down 5% to 7%, compared with prior guidance of down 2% to 8%. The stock has gained 11% in the year to date, while the S&P 500 has gained 94%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-26-23 1642ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
US Stock Market Outlook & Valuation for May 2024
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024 But Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett